Lanean...
A Leishmania infantum genetic marker associated with miltefosine treatment failure for visceral leishmaniasis
BACKGROUND: Miltefosine has been used successfully to treat visceral leishmaniasis (VL) in India, but it was unsuccessful for VL in a clinical trial in Brazil. METHODS: To identify molecular markers that predict VL treatment failure whole genome sequencing of 26 L. infantum isolates, from cured and...
Gorde:
| Argitaratua izan da: | EBioMedicine |
|---|---|
| Egile Nagusiak: | , , , , , , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Elsevier
2018
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6197651/ https://ncbi.nlm.nih.gov/pubmed/30268832 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2018.09.029 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|